Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Tirzepatide is a dual GIP/GLP-1 agonist that has shown even greater weight loss in clinical trials
It has anti-inflammatory and antioxidant effects and also supports serotonin and GABA production which further supports the above recommendations to trial the amino acids
The Fat Loss Mechanism The proposed fat loss mechanism of 5-amino-1MQ operates through several interrelated effects: NNMT inhibition preserves SAM and NAD+ pools Increased NAD+ supports sirtuin activity and mitochondrial function Reduced lipogenesis adipocyte fatty acid synthesis is decreased Enhanced adipocyte metabolism improved adipose tissue function Selective effect on adipocytes relative sparing of other tissues Preclinical studies have shown that 5-amino-1MQ treatment in mice produces: Reduced body fat mass Improved insulin sensitivity Preserved lean mass Favorable effects on liver fat in diet-induced obesity models The Human Clinical Trials Picture As of 2026, human clinical trial activity for 5-amino-1MQ is emerging but not yet mature
The universal conversion formula If your concentration does not match any of the charts above, use this formula
Digestive Changes: Mild nausea or changes in bowel movements, especially with oral dosing
Individuals who may benefit from Vitamin B supplements include those with dietary restrictions (like vegans, who might lack vitamin B12), the elderly, those with certain medical conditions, pregnant women (who may need more Vitamin B9), and anyone with a diagnosed deficiency in one or more Vitamin B nutrients
